Please enable Javascript to use all features and improve your user experience.
ESHO 2024
Programme
People
Search
EN
Back
Scientific session
Session 6
Clinical applications: Radio-chemo-immunotherapy
Appointment
Date:
07/11/2024
Time:
15:45
–
17:15
Location / Stream:
Auditorium (Aula magna)
Chair
Juan Carlos Quero
NN
Dr. Michiel Kroesen
Rotterdam / NL
Programme
15:45
–
16:05
15 Min.
5 Min.
Invited Talk
IT-06
Hyperthermia as an adjuncive treatment in the treatment of tumors: review of studies
Prof. Giammaria Fiorentini (Pesaro / IT)
16:05
–
16:17
9 Min.
3 Min.
Oral Presentation
OP-25
The impact of thermal dose on pathological complete response in locally advanced rectal cancer patients treated with deep regional hyperthermia combined with neoadjuvant chemoradiotherapy: A multi-institutional propensity score matched analysis
Dr. Adela Ademaj (Aarau / CH)
Hyperthermia clinical applications: radio-chemo-immunotherapy
16:17
–
16:29
9 Min.
3 Min.
Oral Presentation
OP-26
Feasibility and tolerance of deep hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: First spanish experience
Dr. Laura Ferrera-Alayón (Las Palmas de Gran Canaria / ES)
Hyperthermia clinical applications: radio-chemo-immunotherapy
16:29
–
16:41
9 Min.
3 Min.
Oral Presentation
OP-27
Hyperthermia enhances spatially-fractionated radiation and immunotherapy in pre-clinical tumor models
Prof. Robert Griffin (Little Rock / US)
Hyperthermia clinical applications: radio-chemo-immunotherapy
16:41
–
16:53
9 Min.
3 Min.
Oral Presentation
OP-28
Phase I study of THE001 (DPPG2-TSL-DOX) combined with regional hyperthermia in patients with locally advanced or metastatic soft tissue sarcoma
Prof. Dr. Lars Lindner (Munich / DE)
Hyperthermia clinical applications: radio-chemo-immunotherapy
16:53
–
16:55
2 Min.
0 Min.
Flash Presentation
FP-25
Enhancing quality of life in bladder cancer patients: leveraging hyperthermia and chemotherapy
Dr. Sopio Badzgaradze (Kutaisi / GE)
Hyperthermia clinical applications: radio-chemo-immunotherapy
16:55
–
16:57
2 Min.
0 Min.
Flash Presentation
FP-26
Numerical study of hyperthermia application for head and neck tumour with varying complexity of the human model
Dr. Marco Di Cristofano (Rome / IT)
Q&A: thermometry, treatment planning, image guide
16:57
–
16:59
2 Min.
0 Min.
Flash Presentation
FP-27
Synergistic nanoparticle-mediated therapies: Enhancing antitumor efficacy through immune modulation and targeted hyperthermia
Dr. Deepika Sharma (Mohali / IN)
Basic research in Hyperthermia: biological-immune response
16:59
–
17:01
2 Min.
0 Min.
Flash Presentation
FP-28
Effect of biocompatible polyacrylic acid-coated iron oxide-based magnetic fluid in inducing programmed cell death in breast cancer cells MCF-7 subsequent to magnetic fluid hyperthermia
Dr. Neeraj Jain (Changa / IN)
Basic research in Hyperthermia: biological-immune response
17:01
–
17:03
2 Min.
0 Min.
Flash Presentation
FP-29
Biological modeling shows thermal enhancement of radiation dose in a pediatric sarcoma patient treated with proton beam therapy and regional deep hyperthermia
Mattia De Lazzari (Göteborg / SE)
Hyperthermia clinical applications: radio-chemo-immunotherapy
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy